Drug
Prt064445 Enoxaparin
Prt064445 Enoxaparin: highest development phase Phase 2, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| PRT064445/Enoxaparin NCT03551730 | Phase 2 | Healthy Volunteers |
Latest
No recent events.
Follow Prt064445 Enoxaparin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.